2412634
Cooperative Agreement
Overview
Grant Description
SBIR Phase II: Biofeedback system for adults with Parkinson's disease
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to create a product for adults with speech disorders who have reduced ability to communicate with the people in their environment.
This project will positively affect the quality of life of users and extend their ability to live productive lives in society.
This project will reduce the overall burden of health care for adults with communicative disorders and the reduced capacity to communicate.
The commercial impact of this project will be to reduce the overall cost of the provision of healthcare services for adults with communication disorders.
It is expected that users will exert a lessened burden on the overall healthcare system and be able to live independently for longer.
This Small Business Innovation Research (SBIR) Phase II project will address the problem of adults' inability to effectively communicate using spoken language as a consequence of age, disorder, or disease.
The opportunity is to build a device to detect and report on communicative disorders in adults who are experiencing a reduction in the ability to speak and be understood.
The objectives of this project are to develop the necessary hardware and software for a device to detect pathological speech produced by adults with communicative disorders in their natural environment.
It is anticipated that this project will result in a tangible commercial device and associated software for adults with speech disorders.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.
Subawards are not planned for this award.
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to create a product for adults with speech disorders who have reduced ability to communicate with the people in their environment.
This project will positively affect the quality of life of users and extend their ability to live productive lives in society.
This project will reduce the overall burden of health care for adults with communicative disorders and the reduced capacity to communicate.
The commercial impact of this project will be to reduce the overall cost of the provision of healthcare services for adults with communication disorders.
It is expected that users will exert a lessened burden on the overall healthcare system and be able to live independently for longer.
This Small Business Innovation Research (SBIR) Phase II project will address the problem of adults' inability to effectively communicate using spoken language as a consequence of age, disorder, or disease.
The opportunity is to build a device to detect and report on communicative disorders in adults who are experiencing a reduction in the ability to speak and be understood.
The objectives of this project are to develop the necessary hardware and software for a device to detect pathological speech produced by adults with communicative disorders in their natural environment.
It is anticipated that this project will result in a tangible commercial device and associated software for adults with speech disorders.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.
Subawards are not planned for this award.
Awardee
Funding Goals
THE GOAL OF THIS FUNDING OPPORTUNITY, "NSF SMALL BUSINESS INNOVATION RESEARCH PHASE II (SBIR)/ SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMS PHASE II", IS IDENTIFIED IN THE LINK: HTTPS://WWW.NSF.GOV/PUBLICATIONS/PUB_SUMM.JSP?ODS_KEY=NSF23516
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Spokane,
Washington
99202-5030
United States
Geographic Scope
Single Zip Code
Quadralynx was awarded
Cooperative Agreement 2412634
worth $983,137
from National Science Foundation in August 2024 with work to be completed primarily in Spokane Washington United States.
The grant
has a duration of 2 years and
was awarded through assistance program 47.084 NSF Technology, Innovation, and Partnerships.
The Cooperative Agreement was awarded through grant opportunity NSF Small Business Innovation Research / Small Business Technology Transfer Phase II Programs (SBIR/STTR Phase II).
SBIR Details
Research Type
SBIR Phase II
Title
SBIR Phase II: Biofeedback system for adults with Parkinsons disease
Abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to create a product for adults with speech disorders who have reduced ability to communicate with the people in their environment. This project will positively affect the quality of life of users and extend their ability to live productive lives in society. This project will reduce the overall burden of health care for adults with communicative disorders and the reduced capacity to communicate. The commercial impact of this project will be to reduce the overall cost of the provision of healthcare services for adults with communication disorders. It is expected that users will exert a lessened burden on the overall healthcare system and be able to live independently for longer.
This Small Business Innovation Research (SBIR) Phase II project will address the problem of adults’ inability to effectively communicate using spoken language as a consequence of age, disorder, or disease. The opportunity is to build a device to detect and report on communicative disorders in adults who are experiencing a reduction in the ability to speak and be understood. The objectives of this project are to develop the necessary hardware and software for a device to detect pathological speech produced by adults with communicative disorders in their natural environment. It is anticipated that this project will result in a tangible commercial device and associated software for adults with speech disorders.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Topic Code
BM
Solicitation Number
NSF 23-516
Status
(Ongoing)
Last Modified 8/27/24
Period of Performance
8/15/24
Start Date
7/31/26
End Date
Funding Split
$983.1K
Federal Obligation
$0.0
Non-Federal Obligation
$983.1K
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
2412634
SAI Number
None
Award ID URI
SAI EXEMPT
Awardee Classifications
Small Business
Awarding Office
491503 TRANSLATIONAL IMPACTS
Funding Office
491503 TRANSLATIONAL IMPACTS
Awardee UEI
C2RUB9FQ45C9
Awardee CAGE
8XYM4
Performance District
WA-05
Senators
Maria Cantwell
Patty Murray
Patty Murray
Modified: 8/27/24